semaglutide overdose side effects Poison centers see high quantity of calls related to overdoses by injectable weight-loss medications, including Ozempic, Wegovy FDA alerts health care providers,

The landscape of medical weight loss has transformed dramatically with the introduction of GLP-1 medications like semaglutide and tirzepatide

To our knowledge, this is the first reported case suggesting the potential role of GLP-1 receptor agonists in slowing the progression of localized scleroderma, possibly due to their anti-fibrotic and anti-inflammatory effects.

The results, for

Novo Nordisk says participants who took the Wegovy pill in clinical trials lost an average of 16.6% of their body weight.

Such bleeding may be called "intermenstrual bleeding." Related

IntroductionInvasive pulmonary aspergillosis (IPA) poses significant diagnostic challenges in immunocompromised patients, with galactomannan (GM) detection s...